<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="4495">Diazoxide</z:chebi> is a putative <z:hpo ids='HP_0001427'>mitochondrial</z:hpo>, ATP-sensitive <z:chebi fb="120" ids="26216">potassium</z:chebi> channel opener that has been implicated in neuroprotection in <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Administered as pretreatment, <z:chebi fb="0" ids="4495">diazoxide</z:chebi> can attenuate <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-related neuronal injury, but little is known about the potential neuroprotective properties of the drug when it is given after the <z:hpo ids='HP_0003674'>onset</z:hpo> of an ischemic insult </plain></SENT>
<SENT sid="2" pm="."><plain>In a previous study, we applied <z:chebi fb="0" ids="4495">diazoxide</z:chebi> after imposing <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C1695782" disease_type="Disease or Syndrome" abbrv="">cerebral hypoperfusion</z:e> by means of permanent, bilateral occlusion of the common carotid arteries (2VO) in rats </plain></SENT>
<SENT sid="3" pm="."><plain>We observed that <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced learning impairment assessed in the <z:mp ids='MP_0001465'>Morris water maze</z:mp>, and microglial activation visualized by immunocytochemistry, were prevented by <z:chebi fb="0" ids="4495">diazoxide</z:chebi> as determined at 13 weeks after 2VO </plain></SENT>
<SENT sid="4" pm="."><plain>However, <z:chebi fb="0" ids="28262">dimethyl sulfoxide</z:chebi>, the organic solvent of <z:chebi fb="0" ids="4495">diazoxide</z:chebi> also prevented <z:e sem="disease" ids="C0233794" disease_type="Mental or Behavioral Dysfunction" abbrv="">memory deficits</z:e>, without any effect on microglial activity </plain></SENT>
<SENT sid="5" pm="."><plain>Therefore, we have repeated our experiments with the use of an inorganic solvent, aqueous <z:chebi fb="0" ids="32145">NaOH</z:chebi> solution in order to clarify the effect of <z:chebi fb="0" ids="4495">diazoxide</z:chebi> independent of <z:chebi fb="0" ids="28262">dimethyl sulfoxide</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>The present results demonstrated that <z:chebi fb="0" ids="4495">diazoxide</z:chebi> alone did not improve learning performance, but it prevented microglial activation in the hippocampus 13 weeks after the <z:hpo ids='HP_0003674'>onset</z:hpo> of 2VO </plain></SENT>
<SENT sid="7" pm="."><plain>These data provide evidence that post-treatment with <z:chebi fb="0" ids="4495">diazoxide</z:chebi> is not effective in impeding a long-term memory deficiency, but it can attenuate <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced microglial activation, independently of the solvent used </plain></SENT>
</text></document>